Early Access — free while we kick the tires
EdgarHawk

Angelakis Michael J

Director

Director
2 filings analyzed · 2 companies · Latest 2025-03-11

Companies

Company Buys Sells Direction
AMERICAN EXPRESS CO AXP 1 0 Net buying
CLARIVATE PLC CLVT 3 0 Net buying

Activity

March 2025
2025-03-11 AMERICAN EXPRESS CO AXP
medium
Buy
3,700 shares
$998,593
Significance 4/10

Director Angelakis buys 3.7K AXP shares at $269.89; stock now -21.6% from 52-week high, down -19.4% in 30 days.

Michael J Angelakis, a Director, acquired 3,700 shares of American Express at $269.89 on 2025-03-07, establishing an initial position in the company. The purchase occurred during a period of material price weakness: the stock stands at $255.39 currently, representing a -21.6% decline from its 52-week high and a -19.4% drop over the past 30 days. Across Angelakis's open-market transaction history spanning multiple stocks, his prior three purchases have delivered an average 90-day return of -6.8% with a 0% win rate, indicating a historical pattern of purchases preceding further declines. The company's fundamentals remain solid with $16.6B in quarterly revenue, $2.5B in net income, and 9.0% annual revenue growth, though the current valuation at a P/E of 15.40 sits in the context of significant recent equity declines.

November 2024
2024-11-22 CLARIVATE PLC CLVT
high
Buy
3,465,000 shares
$17,863,350
Significance 7/10

Director Angelakis purchases 3.46M shares in 3 tranches for $17.9M (avg $5.16) at unprofitable Clarivate amid stock -44.4% from 52-week high.

Michael J Angelakis, a director at Clarivate PLC, executed three separate purchases totaling 3,465,000 shares for $17,863,350.00 across November 20–22, 2024, with a blended average price of $5.16. This represents a substantial new position (pre-transaction holdings were 0 shares) accumulated at prices between $5.11 and $5.19. The timing of this multi-day acquisition occurs while the stock trades at $5.25, down 44.4% from its 52-week high of $9.44 and down 19.6% over the past 30 days. Notably, the company reported negative net income of $-65,600,000.00 in its latest quarter and was unprofitable over its most recent full fiscal year, while revenue declined 1.2% year-over-year. A director's initiation of a multi-million-dollar position in a fundamentally challenged business during a severe drawdown invites investor scrutiny regarding both the director's conviction about recovery prospects and the strategic rationale for accumulation at this juncture.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access